Development of chondroitin sulfate-based mucoadhesive interpenetrating polymeric hydrogels of captopril with adjustable properties as gastro-retentive sustained drug release carriers

Qaiser, Rubina; Pervaiz, Fahad; Hanan, Hanasul; Shoukat, Hina; Nadeem, Muhammad

doi:10.1007/s00289-023-04967-3

Cited by 2 publications

(1 citation statement)

References 67 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgical interventions can rapidly reduce weight but come with inherent risks. Hydrogels, due to their excellent biocompatibility [2], low cost [3] and prolonged presence in the human body [4], have been applied as gastric retention hydrogels in drug delivery [5] and weight management interventions [6].…”

Section: Introductionmentioning

confidence: 99%

Preparation of Biodegradable Chitosan Semi-Interpenetrating Network Hydrogel and Its Application for Gastric Retention

DONG,

ZHANG,

SHENG

et al. 2024

Preprint

View full text Add to dashboard Cite

Gastric retention hydrogels represent a potential material with weight-loss effects and offer an effective solution to address the low bioavailability of drugs in pharmaceutical therapy. This study aims to develop a degradable hydrogel capable of prolonged retention in the stomach, facilitating both weight loss and drug release. Two degradable macromolecular crosslinking agents were synthesized, with acrylamide as the main monomer, mixed with chitosan solution for the preparation of a degradable hydrogel with a semi-interpenetrating network (sIPN) structure initiated by a redox initiator. The morphology and chemical structure of the prepared hydrogels were characterized using analytical techniques such as SEM and FTIR. In vitro drug release experiments demonstrated that the hydrogel achieved controlled drug release, extending the drug's retention time in the stomach. The swelling performance, biocompatibility and degradation properties of the hydrogel in simulated gastric fluid (SGF) were also evaluated. Results indicated that the hydrogel with crosslinking agent ratio 4:6 exhibited a swelling ratio of 2700%, excellent biocompatibility and a weight loss of 7% in SGF over 5 days. The 4:6 hydrogel had a compressive modulus greater than 13 kPa at 60% deformation, demonstrating resistance to gastric peristalsis. Therefore, the chitosan sIPN hydrogel holds promising potential for applications in weight loss and the treatment of gastric diseases.

show abstract

Section: Introductionmentioning

confidence: 99%